![]() |
市场调查报告书
商品编码
1880380
软体机器人医疗应用市场预测至2032年:按产品类型、材料、技术、应用、最终用户和地区分類的全球分析Soft Robotics for Medical Applications Market Forecasts to 2032 - Global Analysis By Product Type, Material, Technology, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2025 年,用于医疗应用的软体机器人市场规模将达到 1.1783 亿美元,到 2032 年将达到 4.6322 亿美元,预测期内复合年增长率为 21.6%。
医学软体机器人是指製造弹性、亲和性的机器人系统,旨在与人体安全互动。这些机器人采用柔软、可弯曲的材料製成,能够模拟自然运动,并在临床操作中提供可控、精细的操作。它们可辅助微创手术、復健治疗、义肢功能、穿戴式医疗设备和诊断操作。其固有的柔软性提高了患者的安全性、舒适度和操作精度,使其非常适合操作刚性机器人技术可能受限的精细或不规则的解剖结构。
固有的安全性和组织相容性
与刚性器材不同,这些系统能够模拟自然肌肉运动,从而减少精细手术过程中的创伤。它们的灵活性使外科医生能够在微创手术中实现更高的精准度。生物材料和软体致动器的进步进一步改善了患者的治疗效果,最大限度地减少了疤痕形成和恢復期。医院正越来越多地采用这些设备,以适应个人化医疗和以患者为中心的护理模式。随着生物相容性聚合物和自适应控制系统的发展,软体机器人正成为下一代外科手术应用的重要组成部分。
高昂的初始成本和投资
先进感测器、人工智慧驱动的控制系统和专用材料的整合推高了製造成本。与传统的刚性机器人相比,小规模医疗机构往往难以证明其成本效益。培训外科医生和工作人员操作这些系统也带来了额外的财务和营运负担。机器人辅助手术有限的报销途径也减缓了其在成本敏感型市场的普及。在规模经济和模组化设计能够降低成本之前,高昂的投资成本仍将是其广泛应用的一大障碍。
新兴经济体(亚太地区)的成长
中国、印度和韩国等国医疗基础设施的快速扩张正在推动对先进外科技术的需求。各国政府正加大对医院现代化建设的投资,并促进机器人系统的国产化。手术量的增加,以及人们对微创技术的日益了解,正在加速这些技术的应用。全球製造商与区域公司之间的合作正在促进技术转移和市场渗透。随着价格分布的降低和培训计画的完善,亚太地区有望成为软体机器人手术的创新中心。
与现有刚性机器人的竞争
像Intuitive Surgical这样的公司已经将其技术推广到世界各地的医院。由于数十年的临床检验和外科医生的熟悉程度,刚性机器人被认为更可靠。为了获得同样的信任,软体机器人必须展现出耐用性、精准性和成本效益。刚性机器人市场领导不断透过人工智慧整合和先进的影像处理技术进行创新,提高了行业标准。如果软体机器人在安全性、适应性和患者疗效方面没有明显的优势,就有可能落后于现有技术。
疫情扰乱了全球外科手术流程,导致择期手术延期,对新型机器人系统的需求下降。生产和供应链的中断进一步延缓了软体机器人设备的应用。然而,新冠疫情也加速了人们对远端辅助手术和远端机器人平台的兴趣,凸显了软体机器人的重要角色。医院越来越重视自动化和韧性,因此对灵活且适应性强的手术器械提出了更高的要求。后疫情时代的策略强调分散式製造、感染控制和数位整合,而这些都与软体机器人的优势不谋而合。
预计在预测期内,软体机器人手术器械细分市场将占据最大的市场份额。
预计在预测期内,软体机器人手术器械领域将占据最大的市场份额。它们能够适应复杂的解剖结构,使其成为神经外科和介入心臟病学等精细手术的理想选择。医院正越来越多地采用这些系统来减少手术创伤并缩短恢復时间。人工智慧驱动的运动控制和触觉回馈的进步正在提高手术精度。生物相容性材料和模组化设计的持续创新正在巩固其主导地位。随着对微创和患者友善解决方案的需求不断增长,预计软体机器人仍将是外科应用领域最大的细分市场。
预计在预测期内,居家医疗领域将以最高的复合年增长率成长。
预计在预测期内,居家医疗领域将实现最高成长率,这主要得益于市场对能够提升患者舒适度的温和型自适应设备的需求。人口老化加剧、慢性病盛行率上升以及居家照护的广泛普及,都推动了软体机器人工具在行动辅助、治疗和日常生活辅助方面的应用。这些技术有助于减轻看护者的负担,增强患者的自主性,并改善患者的健康状况。智慧型穿戴装置和软体机器人组件的创新正在不断拓展其在住宅医疗保健环境中的应用。
预计亚太地区将在预测期内占据最大的市场份额,这主要得益于中国、印度和日本医疗基础设施的持续改善和手术量的成长。各国政府正在推动国内生产和进口替代,以满足日益增长的需求。机器人辅助手术和人工智慧诊断技术的快速普及正在改变该地区的外科手术实践。全球原始设备製造商 (OEM) 与本地企业之间的策略合作正在加速技术转移。
预计北美地区在预测期内将实现最高的复合年增长率,这主要得益于美国和加拿大在外科机器人、智慧手术室和人工智慧诊断技术方面的创新主导。医院正在整合物联网和数据分析技术,以优化工作流程并提高手术精度。监管机构正在简化下一代机器人系统的核准流程,加速其商业化进程。完善的健保报销机制和微创技术的广泛应用也进一步推动了这一成长。
According to Stratistics MRC, the Global Soft Robotics for Medical Applications Market is accounted for $117.83 million in 2025 and is expected to reach $463.22 million by 2032 growing at a CAGR of 21.6% during the forecast period. Soft robotics in medical applications involves creating flexible and bio-friendly robotic systems designed to interact safely with the human body. Built from soft, bendable materials, these robots replicate natural motion and provide controlled, delicate handling during clinical tasks. They support minimally invasive surgery, rehabilitation therapies, prosthetic function, wearable medical devices, and diagnostic operations. Their inherent softness improves patient safety, comfort, and precision, making them suitable for navigating sensitive or irregular anatomical structures where rigid robotic technologies may pose limitations.
Inherent safety and tissue compatibility
Unlike rigid instruments, these systems mimic natural muscle movement, reducing trauma during delicate procedures. Their flexibility allows surgeons to operate with greater precision in minimally invasive interventions. Advances in biomaterials and soft actuators are further enhancing patient outcomes by minimizing scarring and recovery times. Hospitals are increasingly adopting these devices to align with personalized medicine and patient-centric care models. As biocompatible polymers and adaptive control systems evolve, soft robotics are becoming indispensable in next-generation surgical applications.
High initial cost and investment
The integration of advanced sensors, AI-driven control systems, and specialized materials makes manufacturing expensive. Smaller healthcare facilities often struggle to justify the expenditure compared to conventional rigid robotics. Training surgeons and staff to operate these systems adds further financial and operational burden. Limited reimbursement pathways for robotic-assisted procedures also slow adoption in cost-sensitive markets. Until economies of scale and modular designs reduce expenses, high investment will remain a barrier to widespread deployment.
Growth in emerging economies (APAC)
Rapid expansion of healthcare infrastructure in countries like China, India, and South Korea is driving demand for advanced surgical technologies. Governments are investing in hospital modernization and encouraging local production of robotic systems. Rising surgical volumes, coupled with increasing awareness of minimally invasive techniques, are accelerating adoption. Partnerships between global manufacturers and regional players are fostering technology transfer and market penetration. As affordability improves and training programs expand, APAC is poised to become a hub for soft robotic surgical innovation.
Competition from established rigid robotics
Companies like Intuitive Surgical have already entrenched their technologies in hospitals worldwide. Rigid robotics are perceived as more reliable due to decades of clinical validation and surgeon familiarity. Soft robotics must prove their durability, precision, and cost-effectiveness to gain equal trust. Market leaders in rigid robotics continue to innovate with AI integration and advanced imaging, raising the competitive bar. Without clear differentiation in safety, adaptability, and patient outcomes, soft robotics risk slower adoption against entrenched incumbents.
The pandemic disrupted surgical procedures globally, delaying elective surgeries and reducing demand for new robotic systems. Manufacturing and supply chain interruptions further slowed deployment of soft robotic devices. However, COVID-19 accelerated interest in remote-assisted surgery and tele-robotic platforms, where soft robotics can play a vital role. Hospitals began prioritizing automation and resilience, creating opportunities for flexible, adaptive surgical tools. Post-pandemic strategies now emphasize decentralized manufacturing, infection control, and digital integration, all of which align with the strengths of soft robotics.
The soft robotic surgical devices segment is expected to be the largest during the forecast period
The soft robotic surgical devices segment is expected to account for the largest market share during the forecast period, due to their ability to conform to complex anatomical structures makes them ideal for delicate procedures such as neurosurgery and cardiovascular interventions. Hospitals are increasingly adopting these systems to reduce operative trauma and improve recovery times. Advances in AI-driven motion control and haptic feedback are enhancing surgical precision. Continuous innovation in biocompatible materials and modular designs is reinforcing their leadership. As demand for minimally invasive and patient-friendly solutions grows, soft robotics will remain the largest segment in surgical applications.
The home healthcare segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate, driven by the need for gentle, adaptive devices that improve patient comfort. Increasing elderly populations, long-term illnesses, and a broader move toward at-home treatment encourage the use of soft robotic tools for mobility aid, therapy, and everyday assistance. These technologies help lessen caregiver workload, strengthen patient autonomy, and support better health outcomes. Innovations in smart wearables and soft robotic components are expanding their use in residential healthcare settings.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to expanding healthcare infrastructure and rising surgical volumes in China, India, and Japan are key drivers. Governments are promoting local manufacturing and import substitution to meet growing demand. Rapid adoption of robotic-assisted surgery and AI-driven diagnostics is reshaping surgical practices in the region. Strategic collaborations between global OEMs and regional firms are accelerating technology transfer.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the U.S. and Canada are leading innovations in surgical robotics, smart operating rooms, and AI-powered diagnostics. Hospitals are integrating IoT and data analytics to optimize workflows and enhance surgical precision. Regulatory bodies are streamlining approval processes for next-generation robotic systems, encouraging faster commercialization. Strong reimbursement frameworks and high adoption of minimally invasive techniques further support growth.
Key players in the market
Some of the key players in Soft Robotics for Medical Applications Market include Boston Dyn, Kawasaki H, Siemens H, Mitsubishi, Medtronic, ReWalk Rob, Stryker, Ekso Bioni, Johnson &, Ottobock, Intuitive S, Zoll Medic, ABB, GE Health, and Philips He.
In October 2025, Mitsubishi Corporation announce that it has agreed to subscribe for new shares to be issued by Eagers Automotive Ltd. through a strategic placement, and has entered into a Strategic Partnership Agreement to promote collaboration and explore new business opportunities across the automotive and mobility sectors.
In March 2025, Siemens announced that it has completed the acquisition of Altair Engineering Inc., a leading provider of software in the industrial simulation and analysis market, for an enterprise value of approximately USD 10 billion. With this acquisition, Siemens extends its leadership in simulation and industrial artificial intelligence (AI) by adding new capabilities in mechanical and electromagnetic simulation, high-performance computing (HPC), data science and AI.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.